What the research found
The MHRA, working with NHS England, published guidance clarifying that AI scribes ("ambient voice technology") used solely to transcribe, summarise clinical conversations or draft correspondence for a clinician to review are not regulated as medical devices, while any tool that supports diagnosis or treatment (or takes automated action such as placing an order without clinician review) is. The guidance doesn't change the underlying law; it's meant to remove ambiguity NHS organisations, suppliers and clinicians had been asking for as ambient scribing tools spread rapidly across the NHS.
A real-time test of the "clearance is not proof" point: this clears the low-risk administrative layer for faster adoption while explicitly keeping the higher-stakes diagnosis-and-treatment layer inside medical-device oversight, a risk-tiered line healthcare AI needs more of.